Cargando…

Utility of peripheral blood macrophage factor Apo10 and TKTL1 as markers in distinguishing malignant from benign lung nodules: a protocol for a prospective cohort study in Southern China

INTRODUCTION: Lung nodules are one of the most prevalent diseases. Medical imaging methods have a high false positive rate for distinguishing malignant nodules from benign nodules. Therefore, developing new technologies with high accuracy for screening malignant nodules is of great importance for lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Chuanbo, Huang, Qiyu, Liu, Yuying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626805/ https://www.ncbi.nlm.nih.gov/pubmed/37914307 http://dx.doi.org/10.1136/bmjopen-2023-076573

Ejemplares similares

TKTL1 expression in human malign and benign cell lines
por: Kämmerer, Ulrike, et al.
Publicado: (2015)

Elastography in Distinguishing Benign from Malignant Thyroid Nodules
por: Colakoglu, Bulent, et al.
Publicado: (2016)

DNA-methylation profiling distinguishes malignant melanomas from benign nevi
por: Conway, Kathleen, et al.
Publicado: (2011)

The human transketolase-like proteins TKTL1 and TKTL2 are bona fide transketolases
por: Deshpande, Gaurang P., et al.
Publicado: (2019)

Liquid biopsies to distinguish malignant from benign pulmonary nodules
por: Tao, Rui, et al.
Publicado: (2021)

Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma
por: Saman, S., et al.
Publicado: (2019)

Diagnostic accuracy of S-Detect in distinguishing benign and malignant thyroid nodules: A meta-analysis
por: Zhong, Lin, et al.
Publicado: (2022)

Spectral CT-based radiomics signature for distinguishing malignant pulmonary nodules from benign
por: Xu, Hang, et al.
Publicado: (2023)

EDIM-TKTL1/Apo10 Blood Test: An Innate Immune System Based Liquid Biopsy for the Early Detection, Characterization and Targeted Treatment of Cancer
por: Coy, Johannes F.
Publicado: (2017)

A Novel Deep Learning Model to Distinguish Malignant Versus Benign Solid Lung Nodules
por: Wang, Shuwen, et al.
Publicado: (2022)

Evaluation of Radiomics Models Based on Computed Tomography for Distinguishing Between Benign and Malignant Thyroid Nodules
por: Kong, Dan, et al.
Publicado: (2022)

Radiomics as a non-invasive adjunct to Chest CT in distinguishing benign and malignant lung nodules
por: Selvam, Minmini, et al.
Publicado: (2023)

Diagnostic value of peripheral blood eosinophils for benign and malignant pulmonary nodule
por: Xiu, Jiawei, et al.
Publicado: (2023)

A predictive model to distinguish malignant and benign thyroid nodules based on age, gender and ultrasonographic features()
por: Girardi, Fábio Muradás, et al.
Publicado: (2017)

Peripheral Blood Inflammatory Markers Can Predict Benign and Malignant Thyroid Nodules
por: Deng, Yuanyuan, et al.
Publicado: (2022)

Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time
por: Quarato, Carla Maria Irene, et al.
Publicado: (2023)

Evaluation of TKTL1 as a biomarker in serum of prostate cancer patients
por: Tsaur, Igor, et al.
Publicado: (2016)

Utility of gray-scale ultrasound to differentiate benign from malignant thyroid nodules
por: Popli, Manju Bala, et al.
Publicado: (2012)

Pulmonary Multiple Nodules: Benign or Malignant?
por: Liu, Jing, et al.
Publicado: (2018)

Distinguishing benign from malignant liver tumours
por: Heiken, Jay P.
Publicado: (2007)

Distinguishing benign from malignant adrenal masses
por: Francis, Isaac R.
Publicado: (2015)

In utero exposure to radiation and haematological malignancies: pooled analysis of Southern Urals cohorts
por: Schüz, Joachim, et al.
Publicado: (2017)

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
por: Silvestri, Gerard A., et al.
Publicado: (2018)

Improvement of diagnostic efficiency in distinguishing the benign and malignant thyroid nodules via conventional ultrasound combined with ultrasound contrast and elastography
por: Liu, Mei-Juan, et al.
Publicado: (2017)

Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma N-Glycomics
por: Zhang, Zejian, et al.
Publicado: (2021)

Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules
por: Saleh, Husain A, et al.
Publicado: (2010)

Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study
por: Seminog, O O, et al.
Publicado: (2013)

Benign and malignant thyroid nodules with autoimmune thyroiditis
por: Kassi, Georgia N., et al.
Publicado: (2022)

The value of TI-RADS combined with superb micro-vascular imagine in distinguishing benign and malignant thyroid nodules: A meta-analysis
por: Zhu, Changfu, et al.
Publicado: (2022)

Nomogram based on spectral CT quantitative parameters and typical radiological features for distinguishing benign from malignant thyroid micro-nodules
por: Song, Zuhua, et al.
Publicado: (2023)

Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera
por: Yao, Yao, et al.
Publicado: (2023)

Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study
por: Huang, W-Y, et al.
Publicado: (2014)

Benign disease prone to be misdiagnosed as malignant pulmonary nodules: Minute meningothelioid nodules
por: Peng, Xiao‐Xiao, et al.
Publicado: (2019)

Time Difference of Arrival on Contrast-Enhanced Ultrasound in Distinguishing Benign Inflammation From Malignant Peripheral Pulmonary Lesions
por: Tang, Min, et al.
Publicado: (2020)

Cell Surface Vibrations Distinguish Malignant from Benign Cells
por: Wohl, Ishay, et al.
Publicado: (2023)

TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens
por: Schultz, Holger, et al.
Publicado: (2008)

The predictive value of chest computed tomography images, tumor markers, and metabolomics in the identification of benign and malignant pulmonary nodules
por: Xu, Shuhua, et al.
Publicado: (2023)

The hormonal profile of benign breast disease
por: Samoli, E, et al.
Publicado: (2013)

Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings
por: Wilailak, Sarikapan, et al.
Publicado: (2015)

TKTL1 participated in malignant progression of cervical cancer cells via regulating AKT signal mediated PFKFB3 and thus regulating glycolysis
por: Zhu, Yingping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8amhf9h2t02gll7ct71srhdl94